Indeed, echinomycin-treated GPx2 KD tumours were negative for GLUT1, pAMPK and KRT14 but retained KRT8 expression relative to vehicle-treated GPx2 KD tumours which were positive for all four markers (Fig. S5A). This evidence concerns the gene KRT8 and neoplasm.